Seroprevalance of pertussis antibodies in maternal and cord blood of preterm and term infants

Vaccine

Volumn 31, Issue 38, 2013, Pages 4172-4176

  Ercan, Tugba Erener ^a   Sonmez, Cemile ^b   Vural, Mehmet ^a   Erginoz, Ethem ^a   Torunoǧlu, Mehmet Ali ^b   Perk, Yildiz ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b MINISTRY OF HEALTH   (Turkey)

Author keywords

Antibody; Pertussis; Preterm; Term

Indexed keywords

ANTIBODY; HEMAGGLUTININ; MATERNAL ANTIBODY; PERTUSSIS TOXIN;

ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MATERNAL BLOOD; PASSIVE IMMUNIZATION; PERTUSSIS; PLACENTAL TRANSFER; PREMATURITY; PRIORITY JOURNAL; SEROPREVALENCE; STATISTICAL ANALYSIS; UMBILICAL CORD BLOOD;

ANTIBODY; PERTUSSIS; PRETERM; TERM;

ADHESINS, BACTERIAL; ADULT; ANTIBODIES, BACTERIAL; BIRTH WEIGHT; FEMALE; FETAL BLOOD; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; PERTUSSIS TOXIN; SEROEPIDEMIOLOGIC STUDIES; VIRULENCE FACTORS, BORDETELLA; WHOOPING COUGH; YOUNG ADULT;

EID: 84881542321     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.06.088     Document Type: Article

References (30)

1. Mooi F.R., de Greeff S.C. The case for maternal vaccination against pertussis. Lancet Infect Dis 2007, 7:614-624.
2. Van Rie A., Wendelboe A.M., Englund J.A. Role of maternal pertussis antibodies in infants. Pediatr Infect Dis J 2005, 24(5 Suppl):S62-S65.
3. Healy C.M., Munoz F.M., Rench M.A., Halasa N., Edwards K.M., Baker C.J. Prevalence of pertussis antibodies in maternal delivery, cord, and infant serum. J Infect Dis 2004, 190:335-340.
4. Prevention of Pertussis, Tetanus, and Diphtheria Among Pregnant and Postpartum Women and Their Infants: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2008; 57:1-47.
5. D'Angio C.T. Active immunization of premature and low birth-weight infants: a review of immunogenicity, efficacy, and tolerability. Paediatr Drugs 2007, 9:17-32.
6. van den Berg J.P., Westerbeek E.A.M., van der Klis F.R.M., Berbers G.A.M., van Elburg R.M. Transplacental transport of IgG antibodies to preterm infants: a review of the literature. Early Hum Dev 2011, 87:67-72.
7. Malek A., Sager R., Kuhn P., Nicolaides K.H., Schneider H. Evolution of maternofetal transport of immunoglobulins during human pregnancy. Am J Reprod Immunol 1996, 36:248-255.
8. Healy C.M. Vaccines in pregnant women and research initiatives. Clin Obstet Gynecol 2012, 55:474-486.
9. Englund J.A. The influence of maternal immunization on infant immune responses. J Comp Pathol 2007, 137(suppl 1):S16-S19.
10. de Moraes-Pinto M.I., Verhoeff F., Chimsuku L., Milligan P.J., Wesumperuma L., Broadhead R.L., et al. Placental antibody transfer: influence of maternal HIV infection and placental malaria. Arch Dis Child Fetal Neonatal Ed 1998, 79:F202-F205.
11. Centers for Disease Control Prevention Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) in pregnantwomen-Advisory Committee on Immunization Practices (ACIP), 2012. MMWR Morb Mortal Wkly Rep 2013, 62:131-135.
12. Kurugöl Z. Boǧmaca aşi{dotless}si{dotless} ve sorunlar. ANKEM Derg 2011, 25:212-217.
13. Ballard J.L., Khoury J.C., Wedig K., Wang L., Eilers-Walsman B.L., et al. New ballard score, expanded to include extremely premature infants. J Pediatr 1991, 119:417-423.
14. Vatansever U., Cöplü N., Oner N., Sönmez C., Karasalihoglu S., Kurtoglu D., et al. Seroprevalance of Bordetella pertussis antibodies among healthy adolescent girls in Edirne. Swiss Med Wkly 2005, 135:531-536.
15. Coplu N., Esen B., Kurtoglu D., Gozalan A., Miyamura K., Yoshida I. Standardization of an in-house ELISA for pertussis serology and its application in a seroepidemiological study. Mikrobiyol Bul 2005, 39:281-289.
16. Cherry J.D. Immunity to pertussis. Clin Infect Dis 2007, 44:1278-1279.
17. Konda T., Kamachi K., Iwaki M., Matsunaga Y. Distribution of pertussis antibodies among different age groups in Japan. Vaccine 2002, 20:1711-1717.
18. Giammanco A., Chiarini A., Maple P.A., Andrews N., Pebody R., Gay N., et al. European sero-epidemiology network: standardization of the assay results for pertussis. Vaccine 2003, 2:112-120.
19. Baughman A.L., Bisgard K.M., Edwards K.M., Guris D., Decker M.D., Holland K., et al. Establishment of diagnostic cutoff points for levels of serum antibodies to pertussis toxin, filamentous haemagglutinin, and fimbriae in adolescents and adults in the United States. Clin Diagn Lab Immunol 2004, 11:1045-1053.
20. Pebody R.G., Gay N.J., Giammanco A., Baron S., Schellekens J., Tischer A., et al. The seroepidemiology of Bordetella pertussis infection in Western Europe. Epidemiol Infect 2005, 133:159-171.
21. Heininger U., Riffelmann M., Leineweber B., Wirsing von Koenig C.H. Maternally derived antibodies against Bordetella pertussis antigens pertussis toxin and filamentous hemagglutinin in preterm and full term newborns. Pediatr Infect Dis J 2009, 28:443-445.
22. van den Berg J.P., Westerbeek E.A., Berbers G.A., van Gageldonk P.G., van der Klis F.R., van Elburg R.M. Transplacental transport of IgG antibodies specific for pertussis, diphtheria, tetanus, haemophilus influenzae type b, and Neisseria meningitidis serogroup C is lower in preterm compared with term infants. Pediatr Infect Dis J 2010, 29:801-805.
23. de Voer R.M., van der Klis F.R.M., Nooitgedagt J.E., Versteegh F.G.A., Johannes C.M., van Huisseling J.C.M., et al. Seroprevalence and placental transportation of maternal antibodies specific for Neisseria meningitidis serogroup C, Haemophilus influenzae type B, Diphtheria, Tetanus, and Pertussis. Clin Infect Dis 2009, 49:58-64.
24. Gonik B., Puder K.S., Gonik N., Kruger M. Seroprevalence of Bordetella pertussis antibodies in mothers and their newborn infants. Infect Dis Obstet Gynecol 2005, 13:59-61.
25. Van Savage J., Decker M.D., Edwards K.M., Sell S.H., Karzon D.T. Natural history of pertussis antibody in the infant and effect on vaccine response. J Infect Dis 1990, 161:473-479.
26. Nomura M., Kuno-Sakai H., Kimura M., Ichikawa I. Dynamics of transplacental transmission of pertussis antibodies in premature and full-term infants. Tokai J Exp Clin Med 2003, 28:21-26.
27. Simister N.E. Placental transport of immunoglobulin G. Vaccine 2003, 21:3365-3369.
28. Malek A. Ex vivo human placenta models: transport of immunoglobulin G and its subclasses. Vaccine 2003, 21:3362-3364.
29. Shakib J.H., Ralston S., Raissy H.H., Stoddard G.J., Edwards K.M., Byington C.L. Pertussis antibodies in postpartum women and their newborns. J Perinatol 2010, 30:93-97.
30. Malek A., Sager R., Schneider H. Maternal-fetal transport of immunoglobulin G and its subclasses during the third trimester of human pregnancy. Am J Reprod Immunol 1994, 32:8-14.